Relationship between the Crystal Structure and Tuberculostatic Activity of Some 2-Amidinothiosemicarbazone Derivatives of Pyridine. 2022

Katarzyna Gobis, and Małgorzata Szczesio, and Andrzej Olczak, and Tomasz Pawlak, and Ewa Augustynowicz-Kopeć, and Malwina Krause, and Marek L Główka
Department of Organic Chemistry, Medical University of Gdańsk, 107 Gen. Hallera Av., 80-438 Gdansk, Poland.

Tuberculosis remains one of the most common diseases affecting developing countries due to difficult living conditions, the rapidly increasing resistance of M. tuberculosis strains and the small number of effective anti-tuberculosis drugs. This study concerns the relationship between molecular structure observed in a solid-state by X-ray diffraction and the 15N NMR of a group of pyridine derivatives, from which promising activity against M. tuberculosis was reported earlier. It was found that the compounds exist in two tautomeric forms: neutral and zwitterionic. The latter form forced the molecules to adopt a stable, unique, flat frame due to conjugation and the intramolecular hydrogen bond system. As the compounds exist in a zwitterionic form in the crystal state generally showing higher activity against tuberculosis, it may indicate that this geometry of molecules is the "active" form.

UI MeSH Term Description Entries

Related Publications

Katarzyna Gobis, and Małgorzata Szczesio, and Andrzej Olczak, and Tomasz Pawlak, and Ewa Augustynowicz-Kopeć, and Malwina Krause, and Marek L Główka
September 1965, Archives internationales de pharmacodynamie et de therapie,
Katarzyna Gobis, and Małgorzata Szczesio, and Andrzej Olczak, and Tomasz Pawlak, and Ewa Augustynowicz-Kopeć, and Malwina Krause, and Marek L Główka
April 1989, Die Pharmazie,
Katarzyna Gobis, and Małgorzata Szczesio, and Andrzej Olczak, and Tomasz Pawlak, and Ewa Augustynowicz-Kopeć, and Malwina Krause, and Marek L Główka
September 1991, Archiv der Pharmazie,
Katarzyna Gobis, and Małgorzata Szczesio, and Andrzej Olczak, and Tomasz Pawlak, and Ewa Augustynowicz-Kopeć, and Malwina Krause, and Marek L Główka
January 1979, Acta poloniae pharmaceutica,
Katarzyna Gobis, and Małgorzata Szczesio, and Andrzej Olczak, and Tomasz Pawlak, and Ewa Augustynowicz-Kopeć, and Malwina Krause, and Marek L Główka
January 1984, Polish journal of pharmacology and pharmacy,
Katarzyna Gobis, and Małgorzata Szczesio, and Andrzej Olczak, and Tomasz Pawlak, and Ewa Augustynowicz-Kopeć, and Malwina Krause, and Marek L Główka
February 1991, Archiv der Pharmazie,
Katarzyna Gobis, and Małgorzata Szczesio, and Andrzej Olczak, and Tomasz Pawlak, and Ewa Augustynowicz-Kopeć, and Malwina Krause, and Marek L Główka
January 1976, Acta poloniae pharmaceutica,
Katarzyna Gobis, and Małgorzata Szczesio, and Andrzej Olczak, and Tomasz Pawlak, and Ewa Augustynowicz-Kopeć, and Malwina Krause, and Marek L Główka
October 1992, Journal of medicinal chemistry,
Katarzyna Gobis, and Małgorzata Szczesio, and Andrzej Olczak, and Tomasz Pawlak, and Ewa Augustynowicz-Kopeć, and Malwina Krause, and Marek L Główka
November 2020, ACS omega,
Katarzyna Gobis, and Małgorzata Szczesio, and Andrzej Olczak, and Tomasz Pawlak, and Ewa Augustynowicz-Kopeć, and Malwina Krause, and Marek L Główka
July 1999, Arzneimittel-Forschung,
Copied contents to your clipboard!